Literature DB >> 2817115

Chronic medical conditions in a sample of the general population with anxiety, affective, and substance use disorders.

K B Wells1, J M Golding, M A Burnam.   

Abstract

The authors studied the prevalence of eight chronic medical conditions in an adult population sample (N = 2,554) with and without psychiatric disorders. Adjusted for age and sex, the prevalence of any lifetime chronic medical condition for persons with any lifetime affective, anxiety, or substance use disorder was 61.4%, 57.1%, and 57.7%, respectively. Each of these percentages was significantly higher than that for persons with no lifetime psychiatric disorder (53.4%). Both lifetime affective and anxiety disorders were uniquely associated with a greater prevalence of any lifetime chronic medical condition, but the only psychiatric disorders uniquely associated with current (i.e., active) chronic medical conditions were anxiety disorders, suggesting that the association between anxiety disorders and chronic medical conditions develops more quickly than associations between medical conditions and other psychiatric disorders.

Entities:  

Mesh:

Year:  1989        PMID: 2817115     DOI: 10.1176/ajp.146.11.1440

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  25 in total

1.  Correlates of functioning in a population with dual diagnoses: an examination of diagnosis and problem history.

Authors:  L C Jordan; D A Luke; C T Mowbray; S E Herman; W S Davidson; C Conklin
Journal:  J Ment Health Adm       Date:  1996

Review 2.  The costs of depression.

Authors:  Ronald C Kessler
Journal:  Psychiatr Clin North Am       Date:  2011-12-16

3.  Predictors of and health services utilization related to depressive symptoms among elderly Koreans.

Authors:  Jin Hee Shin; Young Kyung Do; Joanna Maselko; Rebecca J N Brouwer; Sang Wook Song; Truls Østbye
Journal:  Soc Sci Med       Date:  2012-04-05       Impact factor: 4.634

4.  Use of psychiatric services by patients in a general hospital.

Authors:  R Mayou; V Seagroatt; M Goldacre
Journal:  BMJ       Date:  1991-10-26

5.  Frequency of deviant immunological test values in chronic fatigue syndrome patients.

Authors:  B H Natelson; S P Ellis; P J Braonáin; J DeLuca; W N Tapp
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

6.  Coprevalence of anxiety and depression with spasmodic dysphonia: a case-control study.

Authors:  Laura J White; Edie R Hapner; Adam M Klein; John M Delgaudio; John J Hanfelt; H A Jinnah; Michael M Johns
Journal:  J Voice       Date:  2011-12-29       Impact factor: 2.009

7.  Effectiveness of collaborative care depression treatment in Veterans' Affairs primary care.

Authors:  Susan C Hedrick; Edmund F Chaney; Bradford Felker; Chuan-Fen Liu; Nicole Hasenberg; Patrick Heagerty; Jan Buchanan; Rocco Bagala; Diane Greenberg; Grady Paden; Stephan D Fihn; Wayne Katon
Journal:  J Gen Intern Med       Date:  2003-01       Impact factor: 5.128

Review 8.  Anxiety disorders and all-cause mortality: systematic review and meta-analysis.

Authors:  Beyon Miloyan; Adam Bulley; Karen Bandeen-Roche; William W Eaton; Daniela C Gonçalves-Bradley
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-09-14       Impact factor: 4.328

Review 9.  Anxiety disorders. Part 1: Diagnosis and treatment.

Authors:  A Labelle; Y D Lapierre
Journal:  Can Fam Physician       Date:  1993-10       Impact factor: 3.275

10.  Opioid therapy in patients with a history of substance abuse.

Authors:  Steven D Passik; Kenneth L Kirsh
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.